PMID- 32799662 OWN - NLM STAT- MEDLINE DCOM- 20210920 LR - 20221207 IS - 1205-7541 (Electronic) IS - 0008-4212 (Linking) VI - 99 IP - 1 DP - 2021 Jan TI - High-methionine diet in skeletal muscle remodeling: epigenetic mechanism of homocysteine-mediated growth retardation. PG - 56-63 LID - 10.1139/cjpp-2020-0093 [doi] AB - Epigenetic DNA methylation (1-carbon metabolism) is crucial for gene imprinting/off-printing that ensures epigenetic memory but also generates a copious amount of homocysteine (Hcy), unequivocally. That is why during pregnancy, expectant mothers are recommended "folic acid" preemptively to avoid birth defects in the young ones because of elevated Hcy levels (i.e., hyperhomocysteinemia (HHcy)). As we know, children born with HHcy have several musculoskeletal abnormalities, including growth retardation. Here, we focus on the gut-dysbiotic microbiome implication(s) that we believe instigates the "1-carbon metabolism" and HHcy causing growth retardation along with skeletal muscle abnormalities. We test our hypothesis whether high-methionine diet (HMD) (an amino acid that is high in red meat), a substrate for Hcy, can cause skeletal muscle and growth retardation, and treatment with probiotics (PB) to mitigate skeletal muscle dysfunction. To test this, we employed cystathionine beta-synthase, CBS deficient mouse (CBS(+/-)) fed with/without HMD and with/without a probiotic (Lactobacillus rhamnosus) in drinking water for 16 weeks. Matrix metalloproteinase (MMP) activity, a hallmark of remodeling, was measured by zymography. Muscle functions were scored via electric stimulation. Our results suggest that compared to the wild-type, CBS(+/-) mice exhibited reduced growth phenotype. MMP-2 activity was robust in CBS(+/-) and HMD effects were successfully attenuated by PB intervention. Electrical stimulation magnitude was decreased in CBS(+/-) and CBS(+/-) treated with HMD. Interestingly; PB mitigated skeletal muscle growth retardation and atrophy. Collectively, results imply that individuals with mild/moderate HHcy seem more prone to skeletal muscle injury and its dysfunction. FAU - Singh, Mahavir AU - Singh M AD - Department of Physiology, University of Louisville School of Medicine, Louisville, KY 40202, USA. FAU - George, Akash K AU - George AK AD - Department of Physiology, University of Louisville School of Medicine, Louisville, KY 40202, USA. FAU - Eyob, Wintana AU - Eyob W AD - College of Arts and Sciences, Case Western Reserve University, 10900 Euclid Ave., Cleveland, OH 44106, USA. FAU - Homme, Rubens P AU - Homme RP AD - Department of Physiology, University of Louisville School of Medicine, Louisville, KY 40202, USA. FAU - Stansic, Dragana AU - Stansic D AD - Department of Dentistry, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia. FAU - Tyagi, Suresh C AU - Tyagi SC AD - Department of Physiology, University of Louisville School of Medicine, Louisville, KY 40202, USA. LA - eng PT - Journal Article DEP - 20200815 PL - Canada TA - Can J Physiol Pharmacol JT - Canadian journal of physiology and pharmacology JID - 0372712 RN - 0LVT1QZ0BA (Homocysteine) RN - AE28F7PNPL (Methionine) RN - EC 3.4.24.24 (Matrix Metalloproteinase 2) RN - EC 3.4.24.24 (Mmp2 protein, mouse) RN - EC 4.2.1.22 (Cystathionine beta-Synthase) SB - IM MH - Animals MH - Cystathionine beta-Synthase/deficiency/genetics MH - DNA Methylation MH - Disease Models, Animal MH - Dysbiosis/*complications/metabolism/microbiology/therapy MH - Epigenesis, Genetic MH - Female MH - Gastrointestinal Microbiome/physiology MH - Growth Disorders/blood/metabolism/pathology/*prevention & control MH - Homocysteine/blood/metabolism MH - Humans MH - Hyperhomocysteinemia/blood/*complications/genetics/metabolism MH - Lacticaseibacillus rhamnosus MH - Male MH - Matrix Metalloproteinase 2/genetics/metabolism MH - Methionine/administration & dosage/metabolism MH - Mice MH - Mice, Transgenic MH - Muscle, Skeletal/metabolism/*pathology MH - Probiotics/*administration & dosage OTO - NOTNLM OT - 1-carbon metabolism OT - cystathionine beta-synthase OT - dysbiose OT - dysbiosis OT - metabolisme du carbone 1 OT - oxyde de trimethylamine OT - phosphatidylethanolamine N-methyltransferase OT - phosphatidylethanolamine N-methyltransferase OT - trimethylamine oxide EDAT- 2020/08/18 06:00 MHDA- 2021/09/21 06:00 CRDT- 2020/08/18 06:00 PHST- 2020/08/18 06:00 [pubmed] PHST- 2021/09/21 06:00 [medline] PHST- 2020/08/18 06:00 [entrez] AID - 10.1139/cjpp-2020-0093 [doi] PST - ppublish SO - Can J Physiol Pharmacol. 2021 Jan;99(1):56-63. doi: 10.1139/cjpp-2020-0093. Epub 2020 Aug 15.